PeptideDB

TZD18

CAS No.: 228577-00-2

TZD18, a novel PPAR alpha/gamma dual agonist, inhibits cell growth and induces apoptosis in human glioblastoma T98G cell
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description TZD18, a novel PPAR alpha/gamma dual agonist, inhibits cell growth and induces apoptosis in human glioblastoma T98G cells.
Synonyms TZD-18, TZD 18
molecular weight 477.57
Molecular formula C27H27NO5S
CAS 228577-00-2
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Zang C, Liu H, Bertz J, Possinger K, Koeffler HP, Elstner E, Eucker J. Induction of endoplasmic reticulum stress response by TZD18, a novel dual ligand for peroxisome proliferator-activated receptor alpha/gamma, in human breast cancer cells. Mol Cancer Ther. 2009 Aug;8(8):2296-307. doi: 10.1158/1535-7163.MCT-09-0347. Epub 2009 Aug 11. PubMed PMID: 19671747. 2. Zang C, Liu H, Waechter M, Eucker J, Bertz J, Possinger K, Koeffler HP, Elstner E. Dual PPARalpha/gamma ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines. Cell Cycle. 2006 Oct;5(19):2237-43. Epub 2006 Oct 1. PubMed PMID: 17102607. 3. Liu H, Zang C, Fenner MH, Liu D, Possinger K, Koeffler HP, Elstner E. Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARalpha/gamma ligand TZD18. Blood. 2006 May 1;107(9):3683-92. Epub 2006 Jan 10. PubMed PMID: 16403907. 4. Liu DC, Zang CB, Liu HY, Possinger K, Fan SG, Elstner E. A novel PPAR alpha/gamma dual agonist inhibits cell growth and induces apoptosis in human glioblastoma T98G cells. Acta Pharmacol Sin. 2004 Oct;25(10):1312-9. PubMed PMID: 15456533.